The World Health Organisation says safety is paramount in vaccine trials to combat the COVID-19 infection, and temporary suspensions are not unusual to evaluate any unexplained illness in a participant. It was responding to a pause in an AstraZeneca COVID-19 trial. For some insights on this, we are now joined via Skype by Head of Department at the National Institute for Communicable Diseases Professor Adrian Puren.
For more news, visit sabcnews.com and also #SABCNews, #Coronavirus, #COVID19, #COVID-19News on Social Media.
